Document is current

Any future updates will be listed below

715 IMM-2510, a novel bispecific antibody targeting PD-L1 and VEGF, exhibits cooperative binding, ADCC activity, and enhanced anti-tumor efficacy, with best-in-class potential

Crossref DOI link: https://doi.org/10.1136/jitc-2025-SITC2025.0715

Published Online: 2025-11-04

Published Print: 2025-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark